Author | Bukowski, Ronald M. author |
---|---|
Title | Biology of Renal Cell Carcinoma [electronic resource] / by Ronald M. Bukowski, James H. Finke, Eric A. Klein |
Imprint | New York, NY : Springer New York, 1995 |
Connect to | http://dx.doi.org/10.1007/978-1-4612-2536-2 |
Descript | XII, 275p. 40 illus. online resource |
I. Molecular Biology of Renal Cell Carcinoma -- 1 Classification of Renal Cell Carcinoma Based on Morphologic and Cytogenetic Correlations -- 2 Molecular Cytogenetic Stratification of Renal Cell Tumors -- 3 Oncogenes in Renal Cell Carcinoma -- 4 Molecular Studies of the VHL Tumor Suppressor Gene in Renal Cell Carcinoma -- 5 The Cloning of Tumor Suppressor Genes from the Short Arm of Human Chromosome 3 that Play a Role in the Development of Renal Cell Carcinoma -- 6 Expression of the Wilmsโ Tumor Suppressor Gene (WT1) in Renal Cell Carcinoma -- II Immunology of Renal Cell Carcinoma -- 7 Alterations in Signal Transduction in T Cells from Cancer Patients -- 8 Impaired Signal Transduction in Tumor Infiltrating T Cells from Patients with Renal Cell Carcinoma -- 9 Recruitment of MHC-Restricted Cytotoxic T Lymphocytes Specific for Renal Cell Carcinoma to the Tumor In Situ -- 10 T-Lymphocyte Response in Renal Cell Carcinoma -- 11 Adhesion Molecules in Renal Cell Carcinoma -- III Novel Therapeutic Approaches in Renal Cell Carcinoma -- A) Genetic Manipulation -- 12 Cellular and Molecular Considerations for the Treatment of Murine Renal Cancer -- 13 2-5A-Antisense: A Novel Approach to Cancer Therapy -- 14 Analysis of Immune Response Induced by Tumors Engineered to Secrete Cytokines -- 15 New Avenues of Cancer Treatment: Modulation of Host Antitumor Directed Immune Responses by IL-4 and IL-12 in Renal Cell Cancer -- B) Cytokines/Adoptive Immunotherapy -- 16 Interleukin 12: Biology and Preclinical Studies of a New Anti-Tumor Cytokine -- 17 Cytokine Therapy of Metastatic Renal Cell Carcinoma: The Cleveland Clinic Experience -- 18 The Use of Cytokines, Tumor Infiltrating Lymphocytes, and Gene Therapy in the Treatment of Advanced Renal Cell Carcinoma: The UCLA Experience -- 19 Inhalational Interleukin-2 in the Treatment of Pulmonary Metastases in Patients with Renal Cell Carcinoma -- 20 Combination Immunotherapy with Interleukin-2 (IL-2), Alpha-Interferon (?IFN), and Autologous IL-2-Activated Lymphocytes (LAK) in Metastatic Renal Cell Cancer -- 21 T Cell Therapy of Patients with Advanced Renal Cell Carcinoma -- 22 Adoptive Immunotherapy with Interleukin-2 and LAK Cells or Gene Modified TIL in Patients with Renal Cell Carcinoma: Clinical and Laboratory Data -- C) Monoclonal Antibodies -- 23 Antibody Localization in Human Renal Cell Carcinoma: A Phase 1 Study of Monoclonal Antibody G250